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Abstract
 
T cell–APC conjugation as mediated by leukocyte function-associated antigen-1 (LFA-1)–
intercellular adhesion molecule (ICAM)-1 binding is followed by formation of the supramo-
lecular activation cluster (SMAC) at the immunological synapse. The intracellular processes
that regulate SMAC formation and its influence on T cell function are important questions to
be addressed. Here, using a mutational approach, we demonstrate that binding of adaptor adhe-
sion and degranulation promoting adaptor protein (ADAP) to SLP-76 differentially regulates
peripheral SMAC (pSMAC) formation relative to conjugation. Although mutation of the
YDDV sites (termed M12) disrupted SLP-76 SH2 domain binding and prevented the ability of
ADAP to increase conjugation and LFA-1 clustering, M12 acted selectively as a dominant
negative (DN) inhibitor of pSMAC formation, an effect that was paralleled by a DN effect on
interleukin-2 production. ADAP also colocalized with LFA-1 at the immunological synapse.
Our findings identify ADAP–SLP-76 binding as a signaling event that differentially regulates
SMAC formation, and support a role for SMAC formation in T cell cytokine production.
Key words: integrins • adaptor proteins • immunological synapse
 
Introduction
 
The interaction of T cells with MHC antigen–bearing
APCs initiates signaling events that are needed for the pro-
liferation and effector function of T cells. The process of con-
jugation is mediated in part by leukocyte function-associated
antigen-1 (LFA-1 or CD11a/CD18) binding to the inter-
cellular adhesion molecules (ICAMs) 1 and 2 on APCs.
Conjugation is accompanied by a rearrangement of recep-
tors that form a supramolecular activation cluster (SMAC)
at the immunological synapse (1–4). The SMAC is com-
prised of a central SMAC enriched with TCR-CD3, CD4,
CD28, and other receptors that are surrounded by a peripheral
SMAC (pSMAC) enriched with LFA-1 and talin (1, 2).
Despite the marked nature of these events, the identity of
the intracellular proteins that regulate SMAC formation has
been unclear, as has the role of the SMAC in influencing T
cell activation. This uncertainty may be related to the oppos-
ing effects of receptor clustering and degradation in the
SMAC (5, 6). Tyrosine phosphorylation and phosphati-
dylinositol 3-kinase (PI-3K) signaling can occur outside the
SMAC (4, 7, 8), and the CD2-associated protein–deficient
T cells show the combined features of unstable SMAC for-
mation and hyperproliferation (9). Alternately, the mere
clustering of receptors and kinases in the central SMAC
would be predicted to facilitate serial ligation of receptors,
repeated kinase activation, and sustained signaling in T cells.
SMAC formation is also needed for the directed release in
viral transmission (10), but is not required for the killing by
cytolytic T cells (11).
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The outer ring of the SMAC (i.e., pSMAC) is comprised
of LFA-1 linked to intracellular proteins talin and RapL
(regulator for cell adhesion and polarization enriched in
lymphoid tissues; references 12, 13). The conversion of
LFA-1 from low to higher affinity forms is a complex pro-
cess that involves conformation changes combined with an
increase in avidity due to clustering (13–15). TCR-CD3 li-
gation and chemokines promote this conversion by means
of inside-out signaling. The process is influenced by various
intracellular signaling proteins such as p56lck, Ras family
member Rap-1, and the exchange complex Cbl–CrkL–
C3G (16, 17). Rap1 binds to its effector molecule RapL
(regulator of adhesion and polarization enriched in lym-
phoid tissues), whereas dominant negative (DN) forms of
RapL can inhibit LFA-1 clustering, ICAM-1 binding, and
T cell–APC conjugation (18). In addition, the head region
of talin can affect conformational changes in LFA-1 (19),
although it may negatively regulate LFA-1 in neutrophils
(20). RhoA has also been linked to the chemokine induc-
tion of high affinity LFA-1 on lymphocytes (21, 22).
Aside from catalytic proteins, adaptor proteins or molec-
ular scaffolds play central roles in the signaling events
needed for T cell function (23, 24). These proteins lack en-
zymatic domains and instead carry binding domains and
sites that are needed for the assembly of complexes. LAT
and SLP-76 (Src homology 2 domain–containing leuko-
cyte protein of 76 kD) couple the TCR complex to the ac-
tivation of phospholipase C
 
 
 
1 (PLC
 
 
 
1), Ca
 
2
 
 
 
 mobiliza-
tion, and NFAT activity (25–29). SLP-76 carries two
NH
 
2
 
-terminal YESP sites that are phosphorylated by ZAP-
70 (Zeta-associated protein-70) and ITK (inducible T cell
kinase)/RLK (resting lymphocyte kinase; references 30–
33), and that bind to the SH2 domain of the hematopoietic
guanine nucleotide exchange factor VAV-1 and the adap-
tor NCK (34–36). The COOH-terminal Src homology 3
domain of Nck can recruit Wiskot Aldrich Syndrome pro-
tein (WASP), whereas the localization and activation of
Cdc42 and WASP requires Vav1 (37). GTP-bound Cdc42
binds the WASP, which in turn regulates the Arp2/3 com-
plex, an initiator of actin filament formation (38).
Although the NH
 
2
 
-terminal region of SLP-76 is needed
for the activation of PLC
 
 
 
1 and Ca
 
2
 
 
 
 mobilization, the
SH2 domain is not needed for these events, but is never-
theless needed, in unexplained ways, for T cell proliferation
(39, 40). In this context, we and others cloned an immune
cell–specific adaptor adhesion and degranulation promoting
adaptor protein (ADAP; previously termed Fyn-T–binding
protein [FYB] or SLP-76–associated protein [SLAP]) that
binds to the SH2 domain of SLP-76 (41, 42). It is also pref-
erentially phosphorylated by p59fyn and binds to the SH2
domain of the kinase (41, 43). Two isoforms (ADAP-120/
130) exist with the 120-kD isoform preferentially expressed
in the thymus and the 130-kD isoform in the peripheral T
cell compartment (44). Each isoform has a proline-rich re-
gion, two putative nuclear localization sites, multiple tyro-
sine sites, and two SH3 domains (41–43). Each isoform also
has two identical ExYDDV motifs (EVY
 
595/Y651
 
 DDV mo-
tifs in ADAP-120) that bind to the SH2 domain of SLP-76,
and a YDGI motif that binds to same domain in p59fyn
(42, 43, 45, 46). A similar DxYDDV site in hematopoetic
protein kinase 1 (HPK-1) binds to the SH2 domain of
BLNK/SLP-65 (47). An alternate YGYI site for SLP-76
SH2 domain binding has been proposed (48), but is the
subject of some uncertainty (46, 47). Further downstream,
ADAP binds to SKAP-55 (49–51), and has an EVH1 (Ena
[enabled]/VASP [vasodilator-stimulated phospho protein]
homology 1 domain) binding site for VASP, a regulator of
actin filament elongation (52).
Although the subject of some initial debate (42), ADAP
positively regulates T cell function as shown in transfection
studies (44, 46) and by the phenotype of the ADAP
 
   
 
mice (53, 54). This was clearly observed in ADAP-defi-
cient mice that show a defect in LFA-1 adhesion and clus-
tering on T cells (53, 54). No defects in other aspects of T
cell signaling were apparent. The adaptor also modulates
 
 
 
1 integrin-dependent cell migration (55) as well as the
clustering and adhesion of 
 
 
 
1 integrins on basophils (56–
58). ADAP can bind to MIST (mast cell immunoreceptor
signal transducer)/Clnk (for cytokine-dependent hemopoi-
etic cell linker), leading to enhanced 
 
 
 
-hexosaminidase re-
lease in mast cells (56–58). A functional connection to
SKAP-55 has been implied by the ability of SKAP-55 to
regulate LFA-1 adhesion/clustering and T cell–APC con-
jugation (59). Loss of the SKAP-55 SH3 domain that binds
ADAP abrogates the ability of SKAP-55 to influence these
events (59).
The combined observation that the SLP-76 SH2 domain
is needed for T cell function and binds to ADAP, an adap-
tor that in turn is needed for LFA-1 adhesion suggested that
this intermolecular interaction might constitute a link in
TCR-CD3–mediated activation of LFA-1 (i.e., inside-out
signaling). In this work, using a mutational approach, we
confirm that ADAP binding to the SLP-76 SH2 domain is
needed for TCR-induced LFA-1 adhesion and T cell–APC
conjugation. In addition, we further show that the ADAP–
SLP-76 interaction differentially regulates pSMAC forma-
tion versus general LFA-1 clustering and conjugation. Al-
though the loss of the SLP-76 SH2 domain binding sites on
ADAP (i.e., M12) interfered with the ability of ADAP to
promote conjugation and general LFA-1 clustering, it did
not operate as a DN. In contrast, the same mutations con-
verted ADAP into a potent DN in the blockade of SMAC
formation, and concurrently, IL-2 production. ADAP also
colocalized with LFA-1 at the immunological synapse. Our
findings identify a specific intermolecular event that couples
the TCR with SMAC formation in T cells, and support a
role for SMAC formation in T cell function.
 
Materials and Methods
 
Cell Culture and Antibodies.
 
Reagents were obtained from the
following sources: anti–mouse ADAP (Transduction Laborato-
ries); TRITC-conjugated phalloidin (Sigma-Aldrich); antihema-
glutinin (HA11; Babco); antiphosphotyrosine (4G10; obtained
from T. Roberts, Dana-Farber Cancer Institute, Boston, MA);
anti–SLP-76 (obtained from P.R. Findell, Syntex, Palo Alto, 
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CA); anti-CD3 and anti-CD11a (BD Biosciences); murine
ICAM-1 human Fc (R&D Systems); fibronectin (Sigma-Aldrich);
hybridoma T8.1/L625 cells (a gift from O. Acuto, Institute Pas-
teur, Paris, France); and tetanus toxoid (Ttox) 830–843 peptide
(Research Genetics). Cells were cultured in DMEM supple-
mented with 200 nM methotrexate, 1 mg/ml G418, 10% FCS,
10 mM Hepes, 2 mM 
 
l
 
-glutamine, 100 U/ml pen/strep, and
5 
 
 
 
 10
 
 
 
5
 
 M 2-mercaptoethanol. Freshly isolated CD4
 
 
 
 T cells
from DO11.10 mice (R. Lechler, Imperial College London, Lon-
don,  England) were cultured in RPMI 1640 medium supple-
mented with 2 mM 
 
l
 
-glutamine, 100 U/ml pen/strep, 10% heat-
inactivated FCS, and 5 
 
 
 
 10
 
 
 
5
 
 M 2-mercaptoethanol. OVA
323–339 peptide was purchased from AnaSpec Inc.
 
Transfection/Infection Protocols.
 
ADAP, GFP, and M12 were
expressed in a pSR
 
 
 
 mammalian expression vector containing an
influenza hemaglutinin (HA) epitope tag at the NH
 
2
 
 terminus
(45, 59). The SH2 domain of SLP-76 was amplified by PCR and
cloned into a pEBG mammalian expression vector containing a
GST epitope tag. Transfection was conducted as described previ-
ously (45). For retroviral infection, ADAP or M12 was cloned
into IRES-GFP–based pMXF5 retroviral expression vector using
BamHI and NotI sites or using the Pinco-GFP–based retroviral
expression vector (C. Casimir, Imperial College London, Lon-
don, England) using BamHI and EcoRI sites, and T cells were
infected as described using the ecotropic Phoenix retroviral pro-
ducer cell line (59, 60). Primary mouse CD4
 
 
 
 cells were isolated
using Dynabeads with mouse anti-CD4 (Dynal Biotech) and
stimulated with Con A (Sigma-Aldrich) for 48 h before infection.
After two washes, CD4
 
 
 
 T cells were cultured and washed in
10
 
 
 
5 
 
M methyl-
 
 
 
-
 
d
 
-manno-pyranoside (Sigma-Aldrich) to re-
move the lectin. After three infections, T cells were collected and
used in the conjugation experiments.
 
T Cell–APC Conjugate Assay.
 
Antigen-induced T cell adhe-
sion was quantified using a colorimetric assay for measuring intra-
cellular succinate dehydronase content with MTT (3(4,5-dime-
thyl-thiazol-2-yl)-2,5-diphenyl tetrazolium bromide) as described
previously (59). Cleaved MTT was dissolved in DMSO, trans-
ferred into a 96-well plate, and measured for optical density at 595
nm using an ELISA reader (Bio-Rad Laboratories). The level of
T8.1 cell adhesion to L625.7-presenting cells was calculated by
subtracting the background signal obtained with L625.7 presenting
cells alone. Alternatively, T8.1 cells were stained with PKH67
green or PKH26 red dyes (Sigma-Aldrich) and seeded on adherent
L625.7 cells. After a period of culture, the supernatant containing
nonadherent T8.1 cells was aspirated, and the remaining cells
were observed by fluorescent microscope. Conjugates between
DO11.10 Tg cells and A20 cells were measured as described previ-
ously (59). Fluorescence was analyzed using a FACSCalibur flow
cytometer (Becton Dickinson) equipped with CELLQuest soft-
ware. Immunoprecipitation and immunoblotting were conducted
as described previously (46, 59). Levels of bound Ab were using
horseradish peroxidase–conjugated rabbit anti–mouse followed by
detection with enhanced chemiluminescence (Amersham Bio-
sciences). Measurements of IL-2 were performed using GFP,
ADAP-GFP, or M12-GFP–infected T8.1 cells cocultured with
L625.7 cells pulsed with different concentrations of Ttox peptide
for 48 h as described previously (44, 46). The supernatants were
collected, and IL-2 was measured using ELISA with rat anti–
mouse IL-2 monoclonal antibody (ELISA Capture) and biotinyl-
ated rat anti–mouse IL-2 monoclonal antibody (ELISA Detection).
 
Integrin Adhesion and Clustering Assays.
 
Binding to ICAM-1
or fibronectin was measured using 96-well flat-bottom plates
coated with 3.4 
 
 
 
g of murine ICAM-1–Fc, 30 
 
 
 
g/ml fibronec-
tin (Sigma-Aldrich), or 10 
 
 
 
g/ml BSA (Sigma-Aldrich) as de-
scribed previously (59). LFA-1 capping on retroviral infected
T8.1 cells was conducted as described previously (59).
 
Immunofluorescent and Confocal Microscopy.
 
Immunofluores-
cence microscopy was conducted as described previously (59).
Cells were incubated with anti-HA antibody, followed by FITC-
labeled secondary antibody and TRITC-labeled phalloidin (Sigma-
Aldrich). Image acquisition was performed with an Eclipse E800
microscope (Nikon) and RT Slider digital camera (Diagnostics,
Inc.). For LFA-1 confocal imaging at the T cell–APC interface,
L625.7 cells were seeded on the 12-mm coverslips in 24-well
plates overnight and pulsed with 2.5 
 
 
 
g/ml Ttox cells for 2 h.
Infected T8.1 cells were added for 30 min followed by fixation
with 2% paraformaldehyde for 20 min at 4
 
 
 
C. Cells were exposed
to in a blocking solution (5% vol/vol FCS and 3% wt/vol BSA in
Perm/Wash buffer; BD Biosciences) for 1 h at 4
 
 
 
C followed by
an incubation with anti-CD11a (1 
 
 
 
g/250 ml) in blocking solu-
tion for 1 h at 4
 
 
 
C. After three washes with 0.1% Tween 20/
PBS, Alexa Fluor 568–conjugated goat anti–rat antibody (1 
 
 
 
g/
250 ml) was incubated with cells for 1 h at 4
 
 
 
C and washed three
times in 0.1% Tween 20/PBS. Cells were viewed under a 63
 
 
 
oil immersion objective using a confocal laser scanning micro-
scope (TCS SP2; Leica) equipped with argon/krypton and he-
lium/neon lasers using excitation wavelengths of 488, 568, and
633 nm as described previously (61). Conjugates were scanned in
the xy-direction every 0.3 
 
 
 
m throughout the z-plane. The face
of the immunological synapse was reconstructed using a maxi-
mum intensity projection (Confocal Software; Leica). The per-
centage of fluorescence intensity at immunological synapse rela-
tive to the whole cell membranes was calculated.
 
Online Supplemental Material.
 
Conjugates and LFA-1 staining
were conducted as before and scanned in the xy-direction every
0.3 
 
 
 
m throughout the z-plane. The face of the immunological
synapse was reconstructed using a maximum intensity projection
(Confocal Software; Leica). Three-dimensional movies were re-
constructed using Volocity software. Online supplemental mate-
rial is available at http://www.jem.org/cgi/content/full/jem.
20040780/DC1.
 
Results
 
ADAP Regulates T Cell–APC Conjugate Formation and
Colocalizes with F-actin at the Immunological Synapse.
 
To
assess whether ADAP can regulate conjugate formation, a
conjugation assay was initially used using a T cell hybrid-
oma T8.1 expressing an antigen receptor for Ttox peptide
in the context of HLA-DR
 
*
 
1102 (62). Adhesion was mea-
sured by use of a 3(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT) assay (Materials and Meth-
ods). Ttox peptide induced a three- to fourfold increase in
T cell adhesion, with maximal binding at 15–30 min, fol-
lowed by a reduction in binding from 30–60 min (Fig. 1 a,
top). Adhesion required the presence of adherent cells be-
cause the binding of T cells to tissue culture plates without
adherent cells was negligible (unpublished data). Transfec-
tion with ADAP resulted in a further two- to threefold in-
crease in T cell binding to APCs in the presence of Ttox.
This resulted in an increase from 35–40 to 80–90% in the
percentage of available T cells to adhere to APCs. ADAP
also increased the binding of T cells in the absence of pep-
tide (i.e., antigen-independent adhesion). Similar results 
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were obtained using an alternate procedure where PKH-67
was used to stain T8.1 cells followed by incubation with
APCs and visualization by incandescent and immunofluo-
rescent microscopy (Fig. 1 b). As was observed in the MTT
assay, ADAP overexpression increased the binding of T
cells to Ttox/APCs by two- to threefold relative to Ttox-
exposed vector control cells. Furthermore, conjugation was
partially dependent on LFA-1 binding to ICAM-1 as shown
by its partial inhibition by anti–LFA-1 (Fig. 1 c). These ef-
fects were observed with a low to moderate three- to four-
fold overexpression of ADAP as detected by blotting (Fig.
1 a, bottom left). Expression of the transfected protein was
confirmed by anti-HA blotting (Fig. 1 a, bottom right). These
observations show that ADAP is capable of increasing con-
jugate formation between T cells and APCs.
ADAP also underwent a change in tyrosine phosphoryla-
tion as a result of incubation between T cells/APCs, as de-
tected by antiphosphotyrosine blotting (Fig. 1 d). This was
time dependent and required the presence of peptide agonist
(lanes 2, 4, 6, 8, 10). Phosphorylation was initially detected
as early as 15 s of culture, peaked from 30 s to 2 min, and
reached a plateau after 10 min. We showed previously that
phosphorylation is stable for hours after anti-CD3 ligation
(43). Little phosphorylation was observed in the absence of
peptide (lanes 1, 3, 5, 7, 9). Other adaptors such as VAV and
LAT also underwent peptide-dependent phosphorylation,
the identity being confirmed by precipitation and blotting
studies (unpublished data). These findings indicate that ADAP
becomes phosphorylated on tyrosine residues during antigen
presentation in an agonist-dependent manner.
ADAP also localized at the interface between T cells and
APCs (Fig. 1 e). Cells were transfected with HA-tagged
ADAP, followed by staining with anti-HA plus FITC-con-
jugated goat anti–mouse. TRITC-labeled phalloidin was
used to visualize F-actin. Although unconjugated cells showed
ADAP throughout the cytoplasm (Fig. 1, top), the adaptor
Figure 1. ADAP increases T
cell–APC conjugation and colo-
calizes with F-actin at the immu-
nological synapse. (a, top) pSR 
vector or ADAP-transfected
T8.1 cells were cocultured with
L625.7 cells (APCs) in the absence
or presence of Ttox peptide for
indicated time. Conjugation was
measured by MTT assay. (bottom)
Lysates of cells transfected with
pSR  vector and ADAP were
blotted for ADAP expression us-
ing anti-ADAP (left) or anti-HA
(right). (b) pSR  or ADAP-
transfected T8.1 cells were stained
with PKH-67 fluorescent dye
and cocultured with APCs for
the indicated time. Bright field
images are shown for one of
each transfection to confirm
equivalent L625.7 cells. Immu-
nofluorescence microscopy images
show the T8.1 cells that bound
to APCs. (c) ADAP enhance-
ment of conjugation is partially
dependent on LFA-1. GFP vector
or ADAP-transfected T8.1 cells
were pretreated with anti–LFA-1
(CD11a and CD18 antibodies)
or untreated, and conjugates
were measured by an MTT assay.
(d) T8.1 and L625.7 cells were
cocultured in the absence or
presence of Ttox for indicated
time, and lystates were subjected
to antiphosphotyrosine blotting.
Bands corresponding to ADAP,
VAV, or LAT were identified by
precipitation and immunoblotting
assays (not depicted). (e) ADAP
transfected T8.1 alone and con-
jugates in the absence or presence
of Ttox, and GFP vector–trans-
fected T8.1 cells were stained
with anti-HA and TRITC-labeled
phalloidin. 
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localized at the T cell–APC contact area of conjugates
formed in the presence and absence of peptide (Fig. 1,
middle, arrows). Often this localization was accompanied
by a concurrent loss of the adaptor in other regions of the
cytoplasm. Ttox-stimulated conjugates had a more com-
pressed localization of ADAP at the interface than observed
in unstimulated conjugates (Fig. 1, bottom middle vs. top
middle). Furthermore, the phalloidin subcap closely over-
lapped with ADAP in stimulated conjugates as shown by
yellow fluorescence (Fig. 1, arrows, overlay of red and
green fluorescence). The overlap was less coincident in
unstimulated conjugates. As a negative control, vector-
transfected cells exhibited no localization (Fig. 1, bottom).
Overall, these observations demonstrate that ADAP can
up-regulate T cell–APC conjugate formation in a process
that is accompanied by changes in the phosphorylation and
localization of ADAP.
 
T Cell–APC Conjugation Depends on SLP-76 Binding Sites
on ADAP.
 
We previously identified two tyrosine-based
motifs (i.e., EVY
 
595/651
 
DDV sites) in ADAP that bind
to the SH2 domains of SLP-76 (45, 46). Therefore, next
we investigated whether SLP-76 binding to ADAP was
needed to couple the TCR with the downstream regula-
tion of conjugation. ADAP mutated at the tyrosine residues
(i.e., Y-F) in these motifs (termed M12) was incorporated
into a pMXF5-GFP–based bicistronic vector for retroviral-
mediated gene transfer (60). FACS profiles showed that
cells expressed moderate levels (i.e., 48–62%) of GFP,
ADAP-GFP, and M12-GFP (Fig. 2). Infected T cells were
generally sorted before their use in conjugation assays. Sig-
nificantly, although ADAP increased conjugate formation,
the M12 mutant had little if any effect (Fig. 2 b). This de-
fect in the function of M12 was also observed in the
PKH26-labeling assay (Fig. 2 c). Although ADAP expres-
sion increased T cell adhesion (middle vs. left), the M12
mutant failed to increase conjugation in the presence of
Ttox. These observations clearly indicate that the two sin-
gle mutations needed for SLP-76 binding interfere with
ADAP enhancement of conjugation.
 
M12 Is Defective in Primary T Cell–APC Conjugation.
 
To confirm this observation in primary T cells, retroviral
gene transfer was used to infect activated CD4 positive
lymph node/spleen cells from transgenic DO11.10 mice
(60, 63). T cells from this mouse expresses a TCR for
Figure 2. T cell–APC conju-
gation depends on SLP-76 binding
sites on ADAP. (a, top) FACS
profiles show the expression
level of GFP, ADAP, or M12 in
retroviral infected T8.1 cells.
(bottom) GFP, ADAP-GFP, and
M12-GFP–infected T8.1 cells
were cocultured with L625.7
cells, and conjugates were assayed
by MTT. (b) GFP, ADAP-GFP,
and M12-GFP–infected T8.1
cells were stained with PKH26
and cocultured with L625.7 cells
in the absence or presence of
Ttox for 30 min. Immunofluo-
rescence microscopy images
show the T8.1 cells that bound
to APCs. (c, top) FACS profiles
show the expression level of GFP,
ADAP, or M12 in retroviral in-
fected DO11.10 mouse Tg cells.
(bottom) GFP, ADAP-GFP, and
M12-GFP–infected DO11.10
Tg cells were cocultured with
PKH26 fluorescent dye-labeled
A20 cells (APCs) in the presence
or absence of OVA peptide for
30 min, and conjugates were
enumerated by a FACS analysis.
Histograms show the percentage
of Tg cells forming conjugates. 
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chicken OVA peptide (residues 323–339), which can be
presented by A20 cells (59). Retroviral gene transfer re-
sulted in expression of GFP, ADAP-GFP, or M12-GFP in
18–27% of cells (Fig. 2 e). Conjugation was assessed by
FACS analysis for the binding of GFP-expressing cells with
PKH26 labeled A20 cells. Exposure to OVA peptide in-
creased conjugation by two- to threefold relative to vector
GFP control cells (i.e., 2–3 to 7–8%; Fig. 2 c). Infection
with ADAP-GFP further increased conjugation with a
two- to threefold shift in binding to APCs (i.e., 7–8 to
20%). In contrast, as noted with the T8.1 cells, the expres-
sion of GFP-M12 failed to increase conjugation. These
findings indicate that ADAP can enhance conjugate forma-
tion of primary murine T cells in a manner analogous to
the T8.1 system, and that the loss of the SLP-76 binding
sites abrogates this effect.
 
SLP-76 SH2 Domain, But Not VASP Binding Mutant,
Blocks Conjugation.
 
Although the loss of the SLP-76 bind-
ing sites abrogated conjugation, it was formally possible that
another as yet identified protein binds the ADAP EVYDDV
sites and acts to couple the TCR with conjugation. To ad-
dress this, the SH2 domain of SLP-76 was expressed as a
GST fusion protein in T cells and assessed for an effect on
conjugation (Fig. 3 a). Although the expression of GST alone
had no effect, expression of GST-SLP-76-SH2 reduced
conjugation to nonpeptide-treated levels. GST and GST-
SLP-76-SH2 were expressed at similar levels as shown in
anti-GST blotting (Fig. 3 a, bottom). SLP-76 SH2 domain
precipitated a major band corresponding to ADAP in addi-
tion to two weak bands (unpublished data). Although tem-
pered by the fact that SH2 domains bind to more than one
protein, the predominate binding to ADAP and its inhibition
in conjugation provides further evidence in support of the
importance of ADAP–SLP-76 interaction in conjugation.
Interestingly, in contrast, we also included a variant of
ADAP with a mutation in the FPPPPDDDI motif (residues
616–624) that had been reported to bind to the EVH1 do-
main of VASP (Fig. 3 b and reference 52). A crucial proline
at residue 617 was substituted with an alanine that disrupts
EVH1 domain binding (termed M617; reference 64). Sur-
prisingly, M617 enhanced conjugation to the same extent
as WT ADAP. Similarly, M617/131/132 with additional
mutations in another possible EVH1 binding motif (i.e.,
FPWPP) at residues 131/132 enhanced conjugation. This
indicates that VASP binding to ADAP at these sites is not
apparently needed for conjugation.
 
ADAP–SLP-76 Binding Regulates Integrin Adhesion and
Clustering.
 
Given the importance of conjugation, it was of
interest to determine whether this interaction was needed
for integrin-mediated adhesion and aggregation (Fig. 4).
Previous studies by ourselves and others have shown a re-
quirement for ADAP expression in integrin binding (53,
54). For this, infected T cells were incubated on plates with
immobilized ICAM-1 and assessed for binding as described
previously (59). Anti-CD3 increased the binding of GFP-
infected control cells to ICAM-1 (Fig. 4 a). ADAP infec-
tion enhanced binding by twofold relative to this control.
In contrast, M12 failed to enhance adhesion. A similar anal-
ysis was conducted using purified fibronectin immobilized
on plates (Fig. 4 b). In this case, the combination of immo-
bilized fibronectin plus anti-CD3 led to a fivefold increase
in binding as compared with BSA-coated plates. Similarly,
ADAP-infected cells showed twofold binding increased
relative to control cells. M12 infection failed to augment
binding, exhibiting binding comparable to the GFP vector
control. Treatment with phorbol ester served as a positive
control for inside-out signaling. These data indicate that
the previously documented importance of ADAP in inte-
grin binding depends on SLP-76 SH2 binding to ADAP.
Because integrin clustering increases the avidity of inte-
grin binding to substrate (65), M12 was next assessed for an
effect on these events (Fig. 4 c). LFA-1 capping was de-
fined by the presence of a discrete polarized cap (59). Anti-
CD3 increased the percentage of vector-transfected control
cells to form LFA-1 caps from 6 to 12%. Infection of cells
with ADAP increased this further by twofold where 22–
25% of T cells showed clustering after 30 min of anti-CD3
stimulation. However, in contrast, expression of M12 failed
to increase levels (Fig. 4 c, bottom right). It also appeared
to have a slight inhibitory effect, reducing clustering below
that observed for vector-infected cells, although this was
not statistically significant as judged by standard deviations.
Figure 3. SLP-76 SH2 domain expression blocks
conjugation, whereas VASP-ADAP binding does not
influence conjugate formation. (a, bottom) GST or
GST-SLP-76-SH2–transfected T8.1 cells were cocul-
tured with APCs for 30 min, and conjugates were
measured by an MTT assay. (bottom) Cell lysates from
GST or GST-SLP-76-SH2–transfected T8.1 cells were
blotted with anti-GST. (b) pSR  vector, ADAP,
M617, and M617/131/132-transfected T8.1 cells were
cocultured with L625.7 cells for 30 min, and conju-
gates were measured by an MTT assay. 
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Clustering of LFA-1 was imaged at the T cell–APC in-
terface in conjugates formed over 30 min in the presence of
Ttox. Anti-CD11a was used followed by an Alexa Fluor
568–conjugated anti–rat staining. Imaging of the immuno-
logical synapse amongst individual conjugates (
 
 
 
40) was
conducted by laser-scanning confocal microscopy. As shown
in Fig. 4 d, LFA-1 could readily be visualized at the inter-
face of T cell–APC conjugates that had been stimulated by
Ttox peptide (Fig. 4 d, top). LFA-1 at the interface was
quantified as the percentage of LFA-1 located in the im-
munological synapse relative to the total surface of the T
cell. There was considerable variation in the level of LFA-1
clustering amongst individual conjugates. Retroviral ex-
pression of ADAP-GFP increased the mean slightly, whereas
M12 failed to support an increase, consistent with the ob-
servation in the capping of surface LFA-1 (Fig. 4 c). M12
also appeared to decrease the mean slightly, although this
was a marginal effect relative to the overall heterogeneity
amongst conjugates. Overall, these observations indicate
that M12 failed to support LFA-1 clustering as determined
by two independent assays.
 
M12 Acts as a DN in Blocking pSMAC Formation and IL-2
Production.
 
Importantly, so far, the importance of ADAP–
SLP-76 binding was evident by the fact that M12 did not
support an increased conjugation and general LFA-1 clus-
tering observed with wild-type ADAP. However, at the
same time, M12 did not act as a potent DN in interfering
with the function of endogenous ADAP. In other words,
M12 did not reduce in a statistically significant manner the
level of conjugation or general LFA-1 clustering below the
vector control. In this regard, SMAC formation is thought
to occur subsequent to general LFA-1 clustering in a pro-
cess that involves the segregation of LFA-1 from the TCR
in the formation of the p- and c-SMAC (1, 2). Given this,
next we assessed whether the characteristic ring-shaped
clustering of LFA-1 at the immunological synapse (i.e.,
the formation of the pSMAC) was influenced by ADAP–
SLP-76 binding. Imaging of the immunological synapse
amongst individual conjugates (
 
 
 
38) was conducted by la-
ser-scanning microscopy as described in Materials and
Methods. Conjugates formed over 30 min in the presence
of Ttox were stained for LFA-1 using CD11a antibody and
Alexa Fluor 568–conjugated anti–rat antibody. ADAP was
stained with anti-ADAP mAb and Cy5-conjugated anti–
mouse. As seen in Fig. 5 a, ADAP staining generally colo-
calized with LFA-1 at the interface with the segregation of
LFA-1 receptors that characterize a pSMAC (Fig. 5, b vs.
c). Anti–LFA-1 staining was visualized perpendicular to the
interfacing APCs in the context of ADAP versus M12 ex-
pression. Samples of pSMAC at the interface between T
cells and APCs are shown in Fig. 5 b (top). Although 53%
of conjugates of GFP-expressing cells showed the presence
of a pSMAC at the immunological synapse (i.e., 21/39
conjugates), there was an increase in pSMAC formation in
cells expressing ADAP-GFP, up to 71% of conjugates (i.e.,
27/38 conjugates). In contrast, M12 had a marked effect as
a DN, whereas only 20% of conjugates possessed a pSMAC
(i.e., 8/39 conjugates; Fig. 5 a, bottom). This represents a
Figure 4. ADAP–SLP-76 binding regulates integrin adhesion and clustering. GFP, ADAP-GFP, and M12-GFP–infected T8.1 cells were unstimulated
or stimulated with 2C11 or PMA for 30 min and incubated on BSA, ICAM-1Fc–coated plates (a) or fibronectin (FN)-coated plates (b). (c) GFP, ADAP-
GFP, and M12-GFP–infected T8.1 cells were stimulated with 2C11 for 30 min, fixed, and stained with anti-CD11a and Alexa Fluor 546–conjugated anti–
rat antibody. Anti–LFA-1 capping was defined by the presence of a discrete polarized cap at one end of the cell. (bottom) Histogram showing the percentage
of T8.1 cells with LFA-1 clustering. (d) GFP, ADAP-GFP, and M12-GFP–infected T8.1 cells were cocultured with Ttox pulsed L625.7 cells for 30 min,
fixed, and stained for LFA-1 as before. Imaging and measurements of staining at the immunological synapse amongst individual conjugates ( 45) were per-
formed by laser-scanning microscopy. (top) DIC image (left) showed the conjugate and fluorescence image (right) showed LFA-1 clustering at the interface
between T8.1 and L625.7 cells. (bottom) Histogram showed the percentage of LFA-1 at the interface relative to the total surface LFA-1. 
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62% reduction in pSMAC formation relative to the GFP
control cells. Three-dimensional views of the pSMAC
formation are shown in Fig. S1 (available at http://www.
jem.org/cgi/content/full/jem.20040780/DC1). A gallery
of the patterns for the different conjugates is shown in Fig.
S2 (available at http://www.jem.org/cgi/content/full/
jem.20040780/DC1). It is noteworthy that, although there
were significant effects of M12 on pSMAC formation, the
overall intensity of LFA-1 at the immunological synapse
was similar for the vector, ADAP, and M12-infected cells,
a result consistent with the notion that general LFA-1 clus-
tering was only marginally affected by M12 (i.e., not a DN).
Therefore, unlike in the case of conjugation and LFA-1
clustering, M12 acted as a potent DN in abrogating the
formation of pSMACs, indicating that SLP-76 binding to
ADAP is needed for pSMAC formation. Thus, although
other processes such as actin polymerization are known to
affect the extent of accumulation of proteins at the immu-
nological synapse, here we have identified an intracellular
event that regulates assembly of the LFA-1–rich pSMAC
while minimally effecting accumulation of LFA-1 at the
immunological synapse itself.
Given that M12 abrogates pSMAC formation, an oppor-
tunity arose to test if disruption of the pSMAC correlated
with an effect on T cell function. Thus, we assessed the ef-
fect of M12 on TCR induction of IL-2 production (Fig. 5
c). The potent effect of M12 on SMAC formation pro-
vided a potential window into the role of SMAC forma-
tion in TCR induction of IL-2 production. We showed
previously that ADAP expression had a slight effect in in-
creasing IL-2 production, although the underlying basis
was not clear (43). Initially, using the same concentration
of Ttox peptide (at 2 
 
 
 
g/ml) as used in the analysis of
pSMAC formation, retroviral expression of ADAP increased
cytokine production slightly at levels comparable to that
observed on pSMAC formation (Fig. 5 c). Similarly, M12
acted as a potent DN in blocking IL-2 production by
 
 
 
50%. This was shown over a range of peptide concentra-
tions (i.e., 0–2 
 
 
 
g/ml) followed by a measurement of IL-2
production using an ELISA assay (Fig. 5 c). Although the
production of IL-2 increased with increasing amounts of
peptide antigen, and ADAP increased this at each concen-
tration, M12 consistently acted as DN in the inhibition of
cytokine production below that of GFP vector–infected
cells. Overall, our findings indicate that, although M12
failed to support an increase in conjugate formation, its
most potent influence was observed at the level of the sub-
sequent events that lead to pSMAC formation and IL-2
production. The similarity in the degree of inhibition of
pSMAC formation and IL-2 production is consistent with a
model whereby proper SMAC formation is needed for the
full induction of IL-2 production in T cells.
 
Discussion
 
Despite the marked nature of receptor rearrangements
at the immunological synapse, an outstanding question has
concerned the identity and nature (i.e., intermolecular bind-
ing) of signaling events that regulate SMAC formation.
Two candidates are talin and RapL that colocalize with
LFA-1 in the pSMAC (1, 18). In this work, we have iden-
tified SLP-76 SH2 domain binding to ADAP (i.e., via
EVYDDV motifs) as a key event that bridges the TCR
complex via inside-out signaling to LFA-1 clustering, ad-
hesion, T cell–APC conjugation, and formation of the
pSMAC. Loss of SLP-76 binding abrogated ADAP poten-
tiation of LFA-1 adhesion/clustering, and as such is likely
to account for the previous findings that ADAP expression
Figure 5. M12 acts as a DN to inhibit pSMAC formation and IL-2
production. (a) Conjugates of GFP, ADAP-GFP, and M12-GFP–infected
T8.1 cells were stained with LFA-1 and ADAP. (b) LFA-1 staining of
conjugates was examined by laser-scanning microscopy. Samples of pSMACs
at the immunological synapse visualized by z-section analysis are shown
(top). Histogram showed the percentage of pSMACs formation at the
immunological synapse (bottom). (c) GFP, ADAP-GFP, and M12-GFP–
infected T8.1 cells were cocultured with L625.7 cells in the presence of
various concentrations of Ttox peptide and followed by a measurement
of IL-2 production by ELISA. 
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is needed for these events (53, 54). Our work further un-
covered a difference in the reliance of pSMAC formation
versus general LFA-1 clustering/conjugation on the ADAP–
SLP-76 interaction. The DN effect of M12 on SMAC, but
not on general LFA-1 clustering/adhesion, pointed to a
special connection between ADAP–SLP-76 binding and
the higher order events that lead to the segregation of re-
ceptors in SMAC formation. This close connection is sup-
ported by the colocalization of ADAP with LFA-1 at the
immunological synapse. Furthermore, our work docu-
ments a correlation between the DN effect of M12 inhibi-
tion on SMAC formation and subsequent IL-2 production,
thereby supporting a model where SMAC formation con-
tributes to cytokine production in T cells.
ADAP joins a number of mediators such as VAV-1,
WASP, WIP, Rap1/RapL, and SKAP-55 that regulate
conjugation (59, 66–69). This was observed in two models
with retroviral gene transfer in T8.1 cells that respond to
Ttox peptide, and in DO11.10 primary T cells that respond
to OVA peptide (Figs. 1 and 3). We previously identified
the two ExYDDV motifs as sites of SLP-76 domain bind-
ing (45, 46), a finding confirmed with BLNK–SLP-65 SH2
binding to a related site DxYDDV in HPK-1 (47). Al-
though our work focused on ADAP-120, the higher 
 
M
 
r
 
isoform ADAP-130 also has the motifs (44), and can poten-
tiate conjugation (unpublished data). Specificity was shown
by the finding that mutations in the putative ADAP EVH1
binding sites (52) had no detrimental effect on conjugation.
VASP acts to prevent the termination of growing actin fila-
ments by competing for the binding of capping proteins
(70). Therefore, VASP–ADAP binding may play other
roles in conjugation, distinct from the regulation of LFA-
1–ICAM-1 binding. Actin branching is generally associated
with lateral extensions at the cell surface (i.e., lamellapodia)
and, therefore, ADAP–VASP may extend the T cell–APC
interface after LFA-1 binding, or play a supplementary
nonessential role in ADAP function. In a similar vein, class
II myosin modulates the cytoskeleton and motility, but not
synapse formation (71). In either case, this involvement of
the ADAP–VASP interaction was clearly distinct from that
of the ADAP–SLP-76 interaction. One a simple level, the
ADAP–SLP-76 interaction would be expected to operate
downstream of TCR-p56lck-ZAP-70–SLP-76–VAV (with
the possible intermediate involvement of LAT and GADS)
and be integrated downstream with its other binding part-
ner SKAP-55. We showed previously that the loss of the
SKAP-55 SH3 domain that binds to ADAP abrogated the
ability of SKAP-55 to enhance T cell–APC conjugation
(59). The pathway is further complicated by the involve-
ment of p59fyn. p59fyn (and not p56lck) mediates phos-
phorylation of ADAP on sites needed for SLP-76 SH2
domain binding (46), and p59fyn-deficient T cells show a
major loss of ADAP phosphorylation (43).
Information on the intracellular process that regulates
SMAC formation has been missing, as has information on
the relationship between general LFA-1 clustering and the
subsequent events that segregate receptors in the SMAC.
TCR-CD3 clustering is controlled by WASP (72), whereas
VAV-1 has been reported to regulate both TCR-CD3 and
LFA-1 clustering (66). The involvement of Vav1 and RapL
appears to occur at the level of general LFA-1 clustering,
before the segregation of receptors leading to SMAC for-
mation clustering (18, 66). Constitutively active Rap1 en-
hances LFA-1 clustering (17), whereas DN RapL blocks
general clustering and conjugation (18). The proximity of
SLP-76 to TCR-CD3 signaling would place ADAP–SLP-
76 upstream of RapL and talin, perhaps operating in con-
junction with SLP-76 binding to VAV1 and NCK during
actin remodelling (36, 37). At the same time, the special
DN effect of M12 on pSMAC formation and the colocal-
ization of ADAP with LFA-1 underscores an additional
close downstream connection to the SMAC (and possibly
RapL and talin). Although ADAP does not coprecipitate
LFA-1 (unpublished data), it must be central to this process
because a single protein with two mutations essentially
eliminated 
 
 
 
50–60% of SMAC formation (Fig. 5 b). Fu-
ture studies will need to be conducted to clarify the con-
nection between ADAP and RapL/talin in the SMAC. An
additional connection to SKAP-55 has also been implied
by SKAP-55 binding to ADAP and its regulation of LFA-1
adhesion/clustering and T cell–APC conjugation (59).
Our findings showing a similarity in the degree of inhibi-
tion of pSMAC formation and IL-2 production suggest a
role for SMAC formation in the full induction of IL-2 pro-
duction in T cells (Fig. 5). Previous studies have been
mixed in their support for a connection between these
events, most likely due to the fact that both the clustering of
receptors (i.e., a positive signal) and receptor internalization
(i.e., probable termination signal) occur in the SMAC (9).
SMAC formation occurs during a decrease in the optimal
levels of tyrosine phosphorylation (9), and early signaling
can occur outside the SMAC (4, 7, 8). T cells from CD2-
associated protein-deficient mice fail to form stable SMACs
and yet hyperproliferate to antigen (9). Despite this, contin-
uous T cell receptor signaling promotes synapse formation
and T cell effector function (73). The DN effect of M12 on
pSMAC formation, but not conjugation, allowed for a dis-
tinction to be made between these events and IL-2 pro-
duction. M12 blocked both SMAC formation and IL-2
production by 
 
 
 
50%, and occasionally, as high as 80% (un-
published data). In this scenario, the limited numbers of
agonist peptide–MHC complexes and continuous receptor
degradation in in vivo responses would be offset by more
effective receptor aggregation and signaling leading to en-
hanced cytokine production. The use of intracellular mu-
tants and genetics may eventually be the most effective way
of uncovering a role for the SMAC in T cell function.
Lastly, the connection between ADAP–SLP-76 and
SMAC formation/IL-2 production provides a molecular
basis to explain previous results showing that SLP-76 can
exert more than one signaling function in T cells. Although
NH
 
2
 
-terminal phosphorylation and the GADS binding
sites are needed for the activation of PLC
 
 
 
1, the SH2 do-
main has been found previously to be needed for prolifera-
tion, but can be dispensed for PLC
 
 
 
1 phosphorylation (39,
40). Unlike in the case of the NH
 
2
 
-terminal tyrosines, the 
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SH2 domain is also not required for progression of thy-
mocytes beyond the pre-TCR stage (CD44
 
 
 
CD25
 
 
 
) of
thymic differentiation (39, 40). The requirement for SLP-
76 SH2 domain binding to ADAP in conjugation and
SMAC formation provides a basis to account for its role in
T cell proliferation.
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